Breast Cancer
Metastatic Left Breast Carcinoma
Female, 37 years
Patient Internal ID: 854138860
ICD-10 code
C50.5 Malignant Neoplasm of Lower Outer Quadrant of Breast
Diagnosis (Incl. Metastases/Stage) and Year
March 2021
Carcinoma of Left Breast ypT2ypN1aM0 G3 LVI-2 ER (-), PR (-), HER2-Negative, Ki67-90% Stage IIB.
Unverified Nodules in Lungs.
Previous Treatment
Chemotherapy (Carboplatin + Paclitaxel), Chemotherapy (Adriamycin and Cyclophosphamide), Surgery,
Radiation Therapy, Chemotherapy (Capecitabine).
Prognosis and Survival Expectation
The prognosis of Triple-Negative Breast Cancer is often poor with lower survival rates and a high risk of recurrence. The 5-year relative survival rates for Triple-Negative Regional Breast Cancer are 66%.
Treatment Provided
Autologous DCV (5 doses) over a period of 4 months. Additionally, the patient received Allogeneic Umbilical Cord Blood Derived NK cells (12 doses) over a period of 11 months and Immunostimulation of Interferon (IFN) β and Tumor Necrosis Factor (TNF).
Patient Survival/Condition and Year
Date of Review: 06/03/2024
The patient has survived for 36 months since the diagnosis with no sign of disease progression. She continues with regular follow-ups. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy, Surgery and Radiation Therapy, has led to cancer remission.
